CEL SCI Valuation
| CVM Stock | USD 0.61 0.01 1.61% |
CEL SCI is undervalued. CEL SCI Corp shows a prevailing Real Value of $2.58 per share. The current price of the firm is $0.61. Our model approximates the value of CEL SCI Corp from examining the firm fundamentals such as Shares Outstanding of 63.81 M, return on equity of -2.5, and Current Valuation of 52.51 M as well as evaluating its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that CEL SCI's price fluctuation is very risky at this time. Calculation of the real value of CEL SCI Corp is based on 3 months time horizon. Increasing CEL SCI's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CEL stock is determined by what a typical buyer is willing to pay for full or partial control of CEL SCI Corp. Since CEL SCI is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CEL Stock. However, CEL SCI's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.61 | Real 2.58 | Hype 0.63 | Naive 0.69 |
The intrinsic value of CEL SCI's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CEL SCI's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CEL SCI Corp helps investors to forecast how CEL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CEL SCI more accurately as focusing exclusively on CEL SCI's fundamentals will not take into account other important factors: CEL SCI Total Value Analysis
CEL SCI Corp is currently anticipated to have company total value of 52.51 M with market capitalization of 44.71 M, debt of 13.57 M, and cash on hands of 22.67 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the CEL SCI fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
52.51 M | 44.71 M | 13.57 M | 22.67 M |
CEL SCI Asset Utilization
One of the ways to look at asset utilization of CEL is to check how much profit was generated for every dollar of assets it reports. CEL SCI Corp shows a negative utilization of assets of -0.61 percent, losing $0.006141 for each dollar of assets held by the firm. Inefficient asset utilization signifies that the company is being less productive with each dollar of assets it shows. Put another way, asset utilization of CEL SCI Corp shows how inadequate it operates for each dollar spent on its assets.CEL SCI Ownership Allocation
CEL SCI holds a total of 63.81 Million outstanding shares. Almost 86.63 percent of CEL SCI outstanding shares are held by general public with 2.91 (percent) owned by insiders and only 10.46 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CEL SCI Profitability Analysis
Reported Net Loss for the year was (32.19 M) with loss before taxes, overhead, and interest of (25.36 M).About CEL SCI Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CEL SCI Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CEL SCI Corp based exclusively on its fundamental and basic technical indicators. By analyzing CEL SCI's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CEL SCI's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CEL SCI. We calculate exposure to CEL SCI's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CEL SCI's related companies.CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company was incorporated in 1983 and is headquartered in Vienna, Virginia. Cel-Sci Corp operates under Biotechnology classification in the United States and is traded on AMEX Exchange.
CEL SCI Growth Indicators
Investing in growth stocks can be very risky. If the company such as CEL SCI does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 44.5 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.